Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cameron J Turtle

Showing results (71-80 of 130) with videos related to

Pageof 13
Sort By:
Journal of Immunological Methods|December 31, 2020
Detection of engineered T cells in FFPE tissue by multiplex in situ hybridization and immunohistochemistryJocelyn H Wright, Li-Ya Huang, Stephanie Weaver, et al.
Science Translational Medicine|September 9, 2016
Immunotherapy of non-Hodgkin's lymphoma with a defined ratio of CD8+ and CD4+ CD19-specific chimeric antigen receptor-modified T cellsCameron J Turtle, Laïla-Aïcha Hanafi, Carolina Berger, et al.
Leukemia|February 16, 2021
Targeting the membrane-proximal C2-set domain of CD33 for improved CD33-directed immunotherapyColin D Godwin, George S Laszlo, Salvatore Fiorenza, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 13, 2017
Graft-Derived Reconstitution of Mucosal-Associated Invariant T Cells after Allogeneic Hematopoietic Cell TransplantationAbir Bhattacharyya, Laïla-Aïcha Hanafi, Alyssa Sheih, et al.
Biorxiv : the Preprint Server for Biology|March 10, 2025
Cytokine-mediated increase in endothelial-leukocyte interaction mediates brain capillary plugging during CAR T cell neurotoxicityLina Park, Yu-Tung Tsai, Hyun-Kyoung Lim, et al.
Blood Advances|February 10, 2025
Protection of CD33-modified hematopoietic stem cell progeny from CD33-directed CAR T cells in rhesus macaquesNicholas E Petty, Stefan Radtke, Greta Kanestrom, et al.
Journal of Cellular and Molecular Medicine|December 1, 2022
Predictors of response to axicabtagene-ciloleucel CAR T cells in aggressive B cell lymphomas: A real-world studyLorenzo Iovino, Qian Vicky Wu, Jenna Voutsinas, et al.
Blood|September 20, 2017
Kinetics and biomarkers of severe cytokine release syndrome after CD19 chimeric antigen receptor-modified T-cell therapyKevin A Hay, Laïla-Aïcha Hanafi, Daniel Li, et al.
Leukemia & Lymphoma|July 11, 2022
Predictors of cytopenias after treatment with axicabtagene ciloleucel in patients with large B-cell lymphomaLorena Panaite, Qian Vicky Wu, Jenna Voutsinas, et al.
Blood|October 31, 2002
Granulocyte-colony stimulating factor increases CD123hi blood dendritic cells with altered CD62L and CCR7 expressionSlavica Vuckovic, Min Kim, Dailal Khalil, et al.
Pageof 13

Showing results (71-80 of 130) with videos related to

Sort By:
Pageof 13
Journal of Immunological Methods|December 31, 2020
Detection of engineered T cells in FFPE tissue by multiplex in situ hybridization and immunohistochemistryJocelyn H Wright, Li-Ya Huang, Stephanie Weaver, et al.
Science Translational Medicine|September 9, 2016
Immunotherapy of non-Hodgkin's lymphoma with a defined ratio of CD8+ and CD4+ CD19-specific chimeric antigen receptor-modified T cellsCameron J Turtle, Laïla-Aïcha Hanafi, Carolina Berger, et al.
Leukemia|February 16, 2021
Targeting the membrane-proximal C2-set domain of CD33 for improved CD33-directed immunotherapyColin D Godwin, George S Laszlo, Salvatore Fiorenza, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 13, 2017
Graft-Derived Reconstitution of Mucosal-Associated Invariant T Cells after Allogeneic Hematopoietic Cell TransplantationAbir Bhattacharyya, Laïla-Aïcha Hanafi, Alyssa Sheih, et al.
Biorxiv : the Preprint Server for Biology|March 10, 2025
Cytokine-mediated increase in endothelial-leukocyte interaction mediates brain capillary plugging during CAR T cell neurotoxicityLina Park, Yu-Tung Tsai, Hyun-Kyoung Lim, et al.
Blood Advances|February 10, 2025
Protection of CD33-modified hematopoietic stem cell progeny from CD33-directed CAR T cells in rhesus macaquesNicholas E Petty, Stefan Radtke, Greta Kanestrom, et al.
Journal of Cellular and Molecular Medicine|December 1, 2022
Predictors of response to axicabtagene-ciloleucel CAR T cells in aggressive B cell lymphomas: A real-world studyLorenzo Iovino, Qian Vicky Wu, Jenna Voutsinas, et al.
Blood|September 20, 2017
Kinetics and biomarkers of severe cytokine release syndrome after CD19 chimeric antigen receptor-modified T-cell therapyKevin A Hay, Laïla-Aïcha Hanafi, Daniel Li, et al.
Leukemia & Lymphoma|July 11, 2022
Predictors of cytopenias after treatment with axicabtagene ciloleucel in patients with large B-cell lymphomaLorena Panaite, Qian Vicky Wu, Jenna Voutsinas, et al.
Blood|October 31, 2002
Granulocyte-colony stimulating factor increases CD123hi blood dendritic cells with altered CD62L and CCR7 expressionSlavica Vuckovic, Min Kim, Dailal Khalil, et al.
Pageof 13